Embedded Files
Eng.
Kittiya Supradit, Ph.D
Kittiya Supradit, Ph.D
Education
พ.ศ. 2565 ปร.ด. (กายวิภาคศาสตร์และชีววิทยาโครงสร้าง) (หลักสูตรนานาชาติ) มหาวิทยาลัยมหิดล
พ.ศ. 2558 วท.บ. (ชีววิทยา) (เกียรตินิยมอันดับหนึ่ง) มหาวิทยาลัยสงขลานครินทร์
Courses under Responsibility
- RDT1002 กายวิภาคศาสตร์ขั้นพื้นฐาน
- RDT2001 สรีรวิทยาขั้นพื้นฐาน
- RDT3001 พื้นฐานกายวิภาคศาสตร์แนวตัด
- RDT3901 ระเบียบวิธีวิจัยและสัมมนาทางรังสีเทคนิค
- RDT4901 ภาคนิพนธ์ 1
- RDT4902 ภาคนิพนธ์ 2
- RDT4003 ประมวลความรู้รังสีเทคนิค
Research Interests
- Cancer cell molecular biology
- miRNA profiling
Publications
Supradit, K., Prasopdee, S., Phanaksri, T., Tangphatsornruang, S., Pholhelm, M., Yusuk,
S., Butthongkomvong, K., Wongprasert, K., Kulsantiwong, J., Chukhan, A., Tesana, S., Thitapakorn, V. (2024) Differential circulating miRNA profiles identified miR-423-5p, miR-93-5p, and miR-4532 as biomarkers for cholangiocarcinoma diagnosis. PeerJ. 12:e18367
Supradit, K., Wongprasert, K., Tangphatsornruang, S., Yoocha, T., Sonthirod, C., Pootakham, W., Thitapakorn, V., Butthongkomvong, K., Phanaksri, T., Kunjantarachot, A., Klongprateeppon, H., Sattavacharavech, P., Prasopdee, S. (2024) MicroRNA profiling of exosomes derived from plasma and their potential as biomarkers for Opisthorchis viverrini-associated cholangiocarcinoma. Acta Tropica. 258:107362.
3. Duangdara, J., Boonsri, B., Sayinta, A., Supradit, K., Thintharua, P., Kumkate, S., Suriyonplengsaeng,C., Larbcharoensub. N., Mingphruedhi, S., Rungsakulkij, N., Muangkaew, P., Tangtawee, P., Vassanasiri, W., Suragul, W., Janvilisri, T., Tohtong, R., Bate, D., Wongprasert, K. (2024) CP-673451, a selective platelet-derived growth factor receptor tyrosine kinase inhibitor, induces apoptosis in opisthorchis viverrini-associated cholangiocarcinoma via nrf2 suppression and enhanced ROS. Pharmaceuticals. 17(1):9.
4. Supradit, K., Boonsri, B., Duangdara, J., Thitiphatphuvanon, T., Suriyonplengsaeng, C., Kangsamaksin, T., Janvilisri, T., Tohtong, R., Yacqub-Usman, K., Grabowska, A.M., Bates, D.O., & Wongprasert, K. (2022) The splicing factor kinase SRPK1 inhibitor prevents cholangiocarcinoma cells induced angiogenesis. Toxicology in vitro. 82:105385.
5. Boonsri, B., Choowongkomon, K., Kuaprasert, B., Thitiphatphuvanon, T., Supradit, K., Sayinta, A., Duangdara, J., Rudtanatip, T., & Wongprasert, K. (2021) Probing the Anti-Cancer Potency of Salfated Galactans on Cholangiocarcinoma Cells Using Synchrotron FTIR Microspectroscopy, Molecular Docking and In Vitro Studies. Marine drugs. 19(5):258.
Conferences
1. Supradit, K., Bates, D.O., & Wongprasert, K. (2021, May 5-7). SRPK1inhibitor regulated alternative VEGF-A splicing switch in cholangiocarcinomacells and attenuated endothelial cells proliferation, migration and tubeformation. The 43rd Annual Conference of Anatomy Association of Thailand,Khonkaen University, Khonkaen, Thailand (Oral presentation) (Prof. WichianDiloksampan Award for best oral presentation in Embryology, MolecularBiology or Biotechnology)
2. Supradit, K., Wongprasert, K., Yacqub-Usman, K., & Bates, D.O. (2019,November 14). Targeting serine-arginine protein kinase 1 (SRPK1)ameliorates pro-angiogenic VEGF165 isoform in cholangiocarcinoma cell lines. Cholangiocarcinoma UK AnnualConference, University of Nottingham, Nottingham, United Kingdom (Oral presentation)
3. Thitapakorn, V., Prasopdee, S., Supradit, K., Wongprasert, K.,Butthongkomvong, K., Sukcharoensin, S., Kunjantarachot, K., Phanaksri, T.,Tesana, S., Yoocha, T., Sonthirod, C., Pootakham, W., & Tangphatsornruang,S. (2019, April 13-16). Differential exosomal mRNA profile of Opisthorchisviverrini infected patient: a potential tool for diagnosis. 29th European Congress of Clinical Microbiology & Infectious Diseases, RAI Amsterdam, Amsterdam, Netherland. (Poster presentation)
Page updated
Report abuse